Larson Financial Group’s Avanos Medical AVNS Stock Holding History

Larson Financial Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11K	Buy	444 +17	+4%	+$398	﹤0.01%	2341
2026 Q1	$5.98K	Sell	427 -32	-7%	-$431	﹤0.01%	2509
2025 Q4	$5.16K	Buy	459 +255	+125%	+$2.92K	﹤0.01%	2448
2025 Q3	$2.36K	Sell	204 -20	-9%	-$234	﹤0.01%	2640
2025 Q2	$2.74K	Buy	224 +34	+18%	+$428	﹤0.01%	2305
2025 Q1	$2.72K	Hold	190	–	–	﹤0.01%	2071
2024 Q4	$3.02K	Hold	190	–	–	﹤0.01%	1786
2024 Q3	$4.57K	Sell	190 -18	-9%	-$411	﹤0.01%	1688
2024 Q2	$4.14K	Buy	208 +204	+5,100%	+$3.97K	﹤0.01%	1480
2024 Q1	$80	Hold	4	–	–	﹤0.01%	1721
2023 Q4	$90	Hold	4	–	–	﹤0.01%	1721
2023 Q3	$81	Hold	4	–	–	﹤0.01%	1665
2023 Q2	$102	Hold	4	–	–	﹤0.01%	1521
2023 Q1	$119	Hold	4	–	–	﹤0.01%	1490
2022 Q4	$108	Hold	4	–	–	﹤0.01%	1454
2022 Q3	$0	Hold	4	–	–	﹤0.01%	1293
2022 Q2	$0	Hold	4	–	–	﹤0.01%	1186
2022 Q1	$0	Hold	4	–	–	﹤0.01%	1039
2021 Q4	$0	Hold	4	–	–	﹤0.01%	1069
2021 Q3	$0	Hold	4	–	–	﹤0.01%	876
2021 Q2	$0	Hold	4	–	–	﹤0.01%	823
2021 Q1	$0	Hold	4	–	–	﹤0.01%	826
2020 Q4	$0	Hold	4	–	–	﹤0.01%	753
2020 Q3	$0	Hold	4	–	–	﹤0.01%	725
2020 Q2	$0	Hold	4	–	–	﹤0.01%	684
2020 Q1	$0	Hold	4	–	–	﹤0.01%	538
2019 Q4	$0	Hold	4	–	–	﹤0.01%	576
2019 Q3	$0	Hold	4	–	–	﹤0.01%	546
2019 Q2	$0	Hold	4	–	–	﹤0.01%	498
2019 Q1	$0	Hold	4	–	–	﹤0.01%	495
2018 Q4	$0	Buy	+4	New	+$210	﹤0.01%	474

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Larson Financial Group's AVNS Position: Q2 2026 in Review

Larson Financial Group increased its Avanos Medical (AVNS) stake by 4% in Q2 2026, buying an estimated $398 and bringing the position to 444 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

Larson Financial Group first reported a position in AVNS in Q4 2018 and has held it in 31 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Larson Financial Group held 444 shares of Avanos Medical worth $11K as of Q2 2026.
Larson Financial Group bought 17 Avanos Medical shares in Q2 2026, an estimated $398.
Avanos Medical made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2341 holding.
Larson Financial Group first reported a position in Avanos Medical in Q4 2018 and has held it in 31 quarters since.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.